Skip to main content
Veterinary Medicines

GALLIMUNE 201 IBD+REO, injekcinė emulsija

Authorised
  • Infectious bursal disease virus, strain VNJO, Inactivated
  • Avian reovirus, strain S1133, Inactivated

Product identification

Medicine name:
GALLIMUNE 201 IBD+REO, injekcinė emulsija
Active substance:
  • Infectious bursal disease virus, strain VNJO, Inactivated
  • Avian reovirus, strain S1133, Inactivated
Target species:
  • Chicken
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Infectious bursal disease virus, strain VNJO, Inactivated
    501187.00
    enzyme-linked immunosorbent assay unit
    /
    0.30
    millilitre(s)
  • Avian reovirus, strain S1133, Inactivated
    10000000.00
    enzyme-linked immunosorbent assay unit
    /
    0.30
    millilitre(s)
Pharmaceutical form:
  • Emulsion for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Chicken
      • Meat and offal
        0
        day
  • Subcutaneous use
    • Chicken
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AA22
Authorisation status:
  • Valid
Authorised in:
  • Lithuania
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health Italia S.p.A. In Breve Boehringer Ingelheim Ah It S.p.A.
Responsible authority:
  • State Food And Veterinary Service
Authorisation number:
This information is not available for this product.
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Lithuanian (PDF)
Published on: 8/12/2022

RV1181.pdf

Lithuanian (PDF)
Published on: 10/06/2022
Download